{"id":464097,"date":"2023-06-15T19:56:54","date_gmt":"2023-06-16T02:56:54","guid":{"rendered":"https:\/\/nai500.com\/blog\/2023\/06\/%e7%a9%ba%e5%a4%b4-%e8%bf%99%e4%b8%a4%e5%8f%aa%e5%9f%ba%e5%9b%a0%e7%bc%96%e8%be%91%e8%82%a1%e7%a5%a8-%e9%80%bc%e7%a9%ba%e8%a1%8c%e6%83%85\/"},"modified":"2023-06-15T19:57:11","modified_gmt":"2023-06-16T02:57:11","slug":"%e7%a9%ba%e9%a0%ad-%e9%80%99%e5%85%a9%e9%9a%bb%e5%9f%ba%e5%9b%a0%e7%b7%a8%e8%bc%af%e8%82%a1%e7%a5%a8-%e9%80%bc%e7%a9%ba%e8%a1%8c%e6%83%85","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2023\/06\/%e7%a9%ba%e9%a0%ad-%e9%80%99%e5%85%a9%e9%9a%bb%e5%9f%ba%e5%9b%a0%e7%b7%a8%e8%bc%af%e8%82%a1%e7%a5%a8-%e9%80%bc%e7%a9%ba%e8%a1%8c%e6%83%85\/","title":{"rendered":"\u7a7a\u982d\u5bc6\u96c6\u7684\u9019\u5169\u96bb\u57fa\u56e0\u7de8\u8f2f\u80a1\u7968\uff0c\u903c\u7a7a\u884c\u60c5\u4e00\u89f8\u5373\u767c\uff01"},"content":{"rendered":"<p>\u903c\u7a7a\u53ef\u4ee5\u5728\u77ed\u6642\u9593\u5167\u5275\u9020\u51fa\u8d85\u984d\u6536\u76ca\uff0c\u56e0\u6b64\u903c\u7a7a\u5019\u9078\u80a1\u4e00\u76f4\u662f\u6295\u6a5f\u8005\u6399\u5feb\u9322\uff0c\u535a\u53d6\u77ed\u671f\u9ad8\u6536\u76ca\u7684\u91cd\u9ede\u95dc\u6ce8\u5c0d\u8c61\u3002\u6700\u8fd1\u5e7e\u5e74\uff0c<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=EDIT\">Editas Medicine Inc\uff08NASDAQ:EDIT\uff09<\/a>\u548c<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=BLUE\">Bluebird bio Inc\uff08NASDAQ:BLUE\uff09<\/a>\u9019\u5169\u96bb\u57fa\u56e0\u7de8\u8f2f\u80a1\u7968\u6210\u70ba\u4e86\u8ce3\u7a7a\u8005\u7684\u91cd\u8981\u76ee\u6a19\u3002<\/p>\n<p>\u4f46\u662f\uff0c\u5c31\u662f\u9019\u5169\u96bb\u4e0d\u88ab\u5e02\u5834\u5f85\u898b\u7684\u751f\u7269\u79d1\u6280\u80a1\u7968\uff0c\u5728\u5229\u597d\u7684\u9a45\u52d5\u4e0b\u53ef\u80fd\u5373\u5c07\u8fce\u4f86\u80a1\u50f9\u7684\u5feb\u901f\u53cd\u5f48\uff0c\u903c\u7a7a\u884c\u60c5\u4e00\u89f8\u5373\u767c\u3002<\/p>\n<h2>Editas Medicine\uff1a\u62d6\u5f8c\u817f\u7684\u57fa\u56e0\u7de8\u8f2f\u80a1\u7968<\/h2>\n<p>\u5c0f\u5e02\u503c\u57fa\u56e0\u7d44\u7de8\u8f2f\u516c\u53f8Editas\u6700\u91cd\u8981\u7684\u7814\u767c\u9805\u76ee\u662f\u9ad4\u5916\u7522\u54c1EDIT-301\uff0c\u76ee\u524dEDIT-301\u6b63\u5728\u9032\u884c\u5169\u96bb\u7f55\u898b\u8840\u6db2\u75c5\uff0c\u942e\u72c0\u7d30\u80de\u75c5\uff08SCD\uff09\u548c\u8f38\u8840\u4f9d\u8cf4\u6027\u03b2\u5730\u4e2d\u6d77\u8ca7\u8840\uff08TBT\uff09\u6cbb\u7642\u7684\u65e9\u671f\u8a66\u9a57\u3002\u6b64\u5916\uff0cEditas\u548c\u767e\u6642\u7f8e\u65bd\u8cb4\u5bf6Bristol-Myers Squibb\uff08NYSE:BMY\uff09\u7684\u514d\u75ab\u816b\u7624\u5408\u4f5c\u8655\u65bc\u81e8\u5e8a\u524d\u958b\u767c\u968e\u6bb5\u3002<\/p>\n<p>\u4e0a\u5e02\u4ee5\u4f86\uff0cEditas\u7684\u80a1\u50f9\u5df2\u7d93\u4e0b\u8dcc\u8fd137%\uff0c\u76f8\u6bd4\u4e4b\u4e0b\uff0cCRISPR Therapeutics AG\uff08NASDAQ:CRSP\uff09\u548cIntellia Therapeutics Inc\uff08NASDAQ:NTLA\uff09\u4e0a\u5e02\u4ee5\u4f86\u5747\u65ac\u7372\u78be\u58d3\u5e02\u5834\u7684\u6f32\u5e45\u3002\u7a76\u5176\u539f\u56e0\uff0cEditas\u5728\u696d\u52d9\u958b\u767c\u5408\u4f5c\u548c\u7522\u54c1\u81e8\u5e8a\u7814\u767c\u65b9\u9762\u90fd\u843d\u5f8c\u4e8e\u9019\u4e9b\u57fa\u56e0\u7d44\u7de8\u8f2f\u80a1\u7968\uff0c\u4eca\u5e74\u516c\u53f8\u9084\u5ba3\u4f48\u91cd\u6574\u8a08\u5283\u3002<\/p>\n<p>\u73fe\u5728\u7684\u554f\u984c\u662f\uff0c\u9019\u53ea\u57fa\u56e0\u7de8\u8f2f\u80a1\u7968\u903c\u7a7a\u884c\u60c5\u7684\u89f8\u767c\u9ede\u662f\u4ec0\u9ebc\uff1f\u9996\u5148\u6392\u9664\u81e8\u5e8a\u7814\u767c\uff0c\u56e0\u6b64\u53ef\u80fd\u7684\u50ac\u5316\u5291\u53ea\u80fd\u4f86\u81ea\u4e8e\u696d\u52d9\u958b\u767c\u5408\u4f5c\u9818\u57df\u3002\u5f9e\u5927\u5c40\u770b\uff0c\u57fa\u56e0\u7de8\u8f2f\u5c07\u6210\u70ba\u4e00\u500b\u91cd\u8981\u7684\u65b0\u7684\u6cbb\u7642\u65b9\u6cd5\uff0c\u56e0\u6b64\u672a\u4f86\u5e7e\u5e74\u4f86\u81ea\u5927\u578b\u88fd\u85e5\u5546\u7684\u5916\u90e8\u6295\u8cc7\u5c07\u6703\u51fa\u73fe\u98c6\u5347\uff0c\u800cEditas\u7684\u57fa\u56e0\u7de8\u8f2f\u5e73\u81fa\u5c07\u53d7\u76ca\u4e8e\u9019\u4e00\u6709\u5229\u8da8\u52e2\u3002\u4e00\u65e6\u5408\u4f5c\u5354\u8b70\u9054\u6210\uff0c\u5c24\u5176\u662f\u5982\u679c\u516c\u53f8\u7372\u5f97\u4e86\u4e00\u5927\u7b46\u7684\u9810\u4ed8\u73fe\u91d1\uff0c\u9019\u5c07\u8db3\u4ee5\u89f8\u767c\u9019\u53ea\u57fa\u56e0\u7de8\u8f2f\u80a1\u7968\u7684\u903c\u7a7a\u884c\u60c5\u3002<\/p>\n<h2>Bluebird Bio\uff1a\u57fa\u56e0\u7642\u6cd5\u9f8d\u982d\u516c\u53f8<\/h2>\n<p>Bluebird Bio\u7121\u7591\u662f\u5168\u7403\u77e5\u540d\u7684\u57fa\u56e0\u7642\u6cd5\u516c\u53f8\uff0c\u4e26\u4e14\u8a72\u751f\u7269\u79d1\u6280\u516c\u53f8\u76ee\u524d\u64c1\u6709\u5169\u6b3e\u8655\u65bc\u5546\u696d\u968e\u6bb5\u7684\u7522\u54c1\uff1a\u6cbb\u7642\u8166\u814e\u4e0a\u817a\u8166\u767d\u8cea\u71df\u990a\u4e0d\u826f\uff08CALD\uff09\u7684Skysona\u4ee5\u53ca\u6cbb\u7642\u03b2\u5730\u4e2d\u6d77\u8ca7\u8840\u7684Zynteglo\u3002\u6b64\u5916\uff0cBluebird\u6700\u8fd1\u9084\u5411\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7ba1\u5c40\uff08FDA\uff09\u63d0\u4ea4\u7b2c\u4e09\u6b3e\u57fa\u56e0\u7642\u6cd5lovo-cel\u7684\u7533\u8acb\uff0c\u8a72\u7642\u6cd5\u91dd\u5c0d\u7684\u662f\u6709\u8840\u7ba1\u9589\u585e\u4e8b\u4ef6\u53f2\uff0c\u5e74\u6eff12\u6b72\u7684\u942e\u72c0\u7d30\u80de\u75c5\u60a3\u8005\u3002\u5982\u679c\u4e00\u5207\u6309\u7167\u8a08\u5283\u9806\u5229\u63a8\u9032\uff0c\u8a72\u516c\u53f8\u52302024\u5e74\u521d\u5c07\u64c1\u67093\u6b3e\u4e0a\u5e02\u7684\u57fa\u56e0\u7642\u6cd5\u3002<\/p>\n<p>\u4e00\u822c\u60c5\u6cc1\u4e0b\uff0c\u85e5\u54c1\u7814\u767c\u548c\u5be9\u6279\u7684\u6210\u529f\u5f80\u5f80\u6703\u4fc3\u4f7f\u4e00\u5bb6\u751f\u7269\u79d1\u6280\u516c\u53f8\u7684\u80a1\u50f9\u66b4\u6f32\uff0c\u4f46\u5728\u7269\u6d41\u554f\u984c\u4ee5\u53ca2024\u5e74\u516c\u53f8\u5c07\u51fa\u73fe\u73fe\u91d1\u77ed\u671f\u7684\u9810\u671f\u4e4b\u4e0b\uff0cBluebird\u7684\u80a1\u50f9\u4e0d\u6f32\u53cd\u8dcc\uff0c\u7a7a\u982d\u5927\u91cf\u6e67\u5165\u3002\u4ed6\u5011\u505a\u7a7a\u9019\u53ea\u57fa\u56e0\u80a1\u7968\u7684\u6838\u5fc3\u4f9d\u64da\u662f\u8a72\u516c\u53f8\u672a\u4f8624\u500b\u6708\u7684\u7d93\u71df\u5c07\u56b4\u91cd\u4f9d\u8cf4\u4e8e\u80a1\u7968\u767c\u884c\u3002<\/p>\n<p>Bluebird\u6703\u4e0d\u6703\u8b93\u6253\u500b\u7a7a\u982d\u5011\u63aa\u624b\u4e0d\u53ca\uff1f\u9019\u7a2e\u53ef\u80fd\u6027\u5b58\u5728\u4f46\u4e0d\u5bb9\u6613\u3002\u95dc\u9375\u9ede\u5728\u65bc\uff0c\u6c92\u6709\u4e00\u500b\u5206\u6790\u5e2b\u9810\u8a08\u9019\u5bb6\u751f\u7269\u79d1\u6280\u516c\u53f8\u4eca\u660e\u5169\u5e74\u5c07\u5be6\u73fe\u73fe\u91d1\u6d41\u8f49\u6b63\u3002\u56e0\u6b64\uff0c\u7ba1\u7406\u5c64\u5fc5\u9808\u5728\u63a8\u52d5\u57fa\u56e0\u65b0\u85e5\u4e0a\u5e02\u7684\u540c\u6642\u89e3\u6c7a\u81ea\u8eab\u7684\u8ca1\u52d9\u554f\u984c\u3002\u597d\u6d88\u606f\u662f\uff0cBluebird\u53ef\u4ee5\u5728\u4e0d\u7a00\u91cb\u80a1\u6771\u6b0a\u76ca\u7684\u540c\u6642\u5be6\u73fe\u4e86\u9019\u4e00\u7d93\u71df\u76ee\u6a19\uff0c\u53ef\u4f9b\u9078\u64c7\u7684\u624b\u6bb5\u5305\u62ec\u7c3d\u7f72\u4e00\u500b\u5927\u578b\u7684\u5408\u4f5c\u5354\u8b70\uff0c\u6216\u8005\u662f\u85e5\u54c1\u7279\u8a31\u6b0a\u5354\u8b70\uff0c\u6216\u8005\u76f4\u63a5\u5c0d\u5916\u51fa\u552e\u3002\u7c21\u55ae\u4f86\u8aaa\uff0c\u8a72\u516c\u53f8\u6709\u8db3\u5920\u7684\u624b\u6bb5\u907f\u514d\u6700\u7cdf\u7cd5\u60c5\u6cc1\u7684\u51fa\u73fe\uff0c\u9019\u5c31\u8db3\u4ee5\u89f8\u767c\u5168\u9762\u7684\u903c\u7a7a\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u903c\u7a7a\u53ef\u4ee5\u5728\u77ed\u6642\u9593\u5167\u5275\u9020\u51fa\u8d85\u984d\u6536\u76ca\uff0c\u56e0\u6b64\u903c\u7a7a\u5019\u9078\u80a1\u4e00\u76f4\u662f\u6295\u6a5f\u8005\u6399\u5feb\u9322\uff0c\u535a\u53d6\u77ed\u671f\u9ad8\u6536\u76ca\u7684\u91cd\u9ede\u95dc\u6ce8\u5c0d\u8c61\u3002\u6700\u8fd1\u5e7e\u5e74\uff0cE [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":464094,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[809,927,563,564],"class_list":["post-464097","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-809","tag-927","tag--zh-hant","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/464097","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=464097"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/464097\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/464094"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=464097"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=464097"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=464097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}